Becker Muscular Dystrophy
54
7
10
30
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
11 trials with published results (20%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
3 terminated out of 54 trials
90.9%
+4.4% vs benchmark
6%
3 trials in Phase 3/4
37%
11 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (54)
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Multimodal Study About Absence of Dp140 in Becker Muscular Dystrophy: Brain-muscle Imaging, Cognition and Muscle Function
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
CureDuchenne Link®: A Resource for Research
Multiparametric Ultrafast Ultrasound Biomarkers for Duchenne and Becker Muscular Dystrophies
Defining Endpoints in Becker Muscular Dystrophy
Duchenne Electronic Health Record Study
The Duchenne Registry
Registry for Duchenne and Becker Muscular Dystrophy
Biomarker Development for Muscular Dystrophies
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)
A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy
Follow-up Study on Female Carriers With DMD Gene Variants
Muscle MRI Outlining of Neuromuscular Diseases Using Artificial Intelligence
Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.
UTSW HP [13-C] Pyruvate Injection in HCM
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD